General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novo Nordisk Inc.(SIGNIFICANT), CRISPR Therapeutics(MODEST), Novartis Corporation(MODEST) SPEAKER'S BUREAU: AstraZeneca Pharmaceuticals(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT)

View Full Disclosure